TI
TBIO

Trexquant Investment’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Trexquant Investment’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,027
Closed -$462K – 1659
2021
Q1 		$462K Buy
28,027
+5,559
+25% +$127K 0.04% 543
2020
Q4 		$414K Sell
22,468
-28,772
-56% -$515K 0.04% 521
2020
Q3 		$697K Sell
51,240
-30,647
-37% -$472K 0.04% 545
2020
Q2 		$1.47M Buy
+81,887
New +$1.23M 0.1% 279

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trexquant Investment's TBIO Position: Q2 2021 in Review

Trexquant Investment sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 28,027 shares — an estimated $462K sold.

Trexquant Investment first reported a position in TBIO in Q2 2020 and held it in 4 quarters. The position peaked at $1.47M in Q2 2020. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Trexquant Investment reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Trexquant Investment sold 28,027 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $462K.
  • Trexquant Investment first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Trexquant Investment's Translate Bio, Inc. Common Stock position peaked at $1.47M in Q2 2020.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Trexquant Investment's 13F filing for Q2 2021, filed 12 Aug 2021.